Look at BMI along with waist size, activity level, and body composition when possible [22]
In Conclusion Until there is more evidence-based research on the impact of GLC-1 receptor agonists on anesthesia, specifically conscious sedation, DOCS Education recommends a medical consult with the patients PCP or endocrinologist, and absent the strong recommendation to the contrary from their prescribing physician, have the patient withhold their weekly injectable GLP-1 receptor antagonist one week before sedation, and their daily GLP-1 receptor agonist on the day of the sedation appointment, and be NPO 6 hours before the appointment as usual
Beyond statistical significance on isolated endpoints, findings from this umbrella review indicate a shift in the management of metabolic diseases from single-metric control to an integrated, multi-organ and multi-risk-factor strategy
Nevertheless, when symptoms correlate closely with treatment initiation or dose changes, medication involvement becomes more likely
The program targets adults who meet medical criteria for GLP-1 medications, typically those with a BMI of 30 or higher or 27+ with weight-related health conditions, and who want more support than a prescription alone